Johnson & Johnson (JNJ) — Stock analysis
USDCurrent price
227,95 USD
-2,85 USD (-1.23%) today
Market signals
About Johnson & Johnson
Johnson & Johnson is one of the largest healthcare companies in the world. After the 2023 Kenvue spin-off (which carried out consumer products like Band-Aid and Tylenol), J&J focuses on two businesses: Innovative Medicine (on-patent drugs in oncology, immunology, neuroscience) and MedTech (medical devices, robotic surgery, orthopedics). Headquartered in New Brunswick, New Jersey.
What does Johnson & Johnson do?▾
J&J makes innovative drugs (oncology, immunology, neuroscience) and medical devices (surgery, orthopedics, ophthalmology). Since 2023 consumer products (Band-Aid, Tylenol, Johnson's Baby) are in a separate company, Kenvue.
Is Johnson & Johnson a defensive stock?▾
Yes, historically. The healthcare business is less cyclical than tech, finance or consumer discretionary. Typical beta 0.4-0.6. Dividend growing for over 60 consecutive years (one of the Dividend Kings).
Does Johnson & Johnson pay dividends?▾
Yes. It pays a quarterly dividend raised annually for over 60 consecutive years — it's a "Dividend King". Yield is typically 2.8-3.3%.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits